Latest Releases
Klobuchar, Smith Secure Funding for Projects to Benefit Scott County
WASHINGTON – U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) announced that they secured federal funding in the Fiscal Year 2024 federal budget for projects to benefit Scott County and surrounding areas. These projects will invest in public trails, workforce development, and mental health services. Klobuchar and Smith requested the funding along with U.S. Representative Angie Craig (D-MN). “From building a trail in Prior Lake to investing in workforce development in Shakopee, we worked with local leaders to secure resources for important community initiatives,” said Klobuchar. “Once completed, these projects will improve career opportunities, mental health care, and public outdoor recreation for Scott County.” “Those closest to an issue have the best solutions, and these projects were developed and designed to fit the specific needs of Scott County,” said Smith. “From promoting economic development to supporting neighbors living with mental illness, these projects will help strengthen our communities.” Klobuchar and Smith have successfully secured: Klobuchar and Smith have been actively involved in securing this federal funding for projects benefiting communities across the state through a process called “Congressionally Directed Spending” (CDS). During the CDS process, Klobuchar and Smith have considered project proposals and advocated for funding in close coordination with leaders from across the state. Projects are expected to receive funding over the next several months. ###
Klobuchar, Smith Secure Funding for Substance Use Treatment Program in Hubbard and Beltrami Counties
WASHINGTON – U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) announced that they secured $550,000 in funding in the Fiscal Year 2024 federal budget to implement the Stratis Health CIRCLE of Care program in Hubbard and Beltrami Counties. The project is a substance use treatment program aimed at reducing morbidity and mortality for those with opioid use disorder (OUD). “The opioid epidemic has been hurting communities across Minnesota for far too long,” said Klobuchar. “With this funding, Stratis Health will have resources to expand proven treatment programs to additional counties to bolster access to treatment for those who are living with substance use disorder.” “Supporting mental health and substance use disorder services is essential—mental health is health, and we need to make sure more people get the care they need,” said Smith. “This funding will help people in Hubbard and Beltrami access life-saving substance use treatment.” Klobuchar and Smith have been actively involved in securing this federal funding for projects benefiting communities across the state through a process called “Congressionally Directed Spending” (CDS). During the CDS process, Klobuchar and Smith have considered project proposals and advocated for funding in close coordination with leaders from across the state. Projects are expected to receive funding over the next several months. ###
Following Request from Klobuchar, Smith, and Colleagues, Administration Releases Funding for Home Energy Assistance Program
WASHINGTON – Following their letter last month, U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) announced that the Administration has released $3.36 billion for federal heating assistance funds to help low-income families and seniors on fixed incomes afford to heat their homes this winter. With colder weather approaching and energy costs projected to increase this winter, the senators said that quick action is especially important as the coronavirus pandemic has added financial hardships for millions of households. In the October letter to Health and Human Services Secretary Alex Azar, who oversees the Low-Income Home Energy Assistance Program (LIHEAP), the
Klobuchar, Sanders, Smith, Colleagues Urge Administration to Send Medical Staff to Support States with Rise in Coronavirus Infections
WASHINGTON – Today, U.S. Senators Amy Klobuchar (D-MN), Bernie Sanders (I-VT), Tina Smith (D-MN), and a group of colleagues sent a letter to U.S. Federal Emergency Management Agency (FEMA) Administrator Peter Gaynor and Department of Health and Human Services (HHS) Secretary Alex Azar, urging the Administration to address the unprecedented rise in coronavirus infections and hospitalizations by swiftly responding to state requests for additional medical staff. This week, hospitalizations due to coronavirus infection peaked in at least 22 states, and 23 states currently have over 1,000 patients hospitalized with coronavirus infections. Klobuchar, Sanders, and Smith were joined by Senators Kyrsten Sinema
U.S. Senator Tina Smith Leads Bipartisan Push to Protect Minnesota Air National Guard Aircraft from Elimination
WASHINGTON, D.C. [11/12/20]—This week, U.S. Senator Tina Smith (D-Minn.) led a bipartisan Senate coalition advocating for a large enough C-130 aircraft fleet in Minnesota and across the country to support active duty missions as well as respond to disasters and emergencies at home. After news that the Air Force was considering reductions in the size of the C-130 fleet, last month Sen. Smith and the Minnesota Congressional delegation called on the Secretary of the Air Force, Barbara Barrett, to maintain the size of the C-130 fleet while making the most efficient use of taxpayer dollars. The 133rd Airlift Wing, stationed
U.S. Senators Tina Smith, Elizabeth Warren Question FDA On Safety Inspections for Foreign Pharmaceuticals Entering the United States
WASHINGTON, D.C. [11/10/20]— U.S. Senator Tina Smith (D-Minn.) and Elizabeth Warren (D-Mass.) sent a letter to the U.S. Food and Drug Administration (FDA) inquiring about the agency’s quality and safety inspections for pharmaceuticals and drug products entering the United States. Under normal operating procedures, the FDA inspects manufacturing facilities and is responsible for maintaining the safety, effectiveness, quality, and security of drugs produced in the United States and abroad. However, due to the coronavirus (COVID-19) pandemic, the FDA postponed all inspections of domestic and foreign drug manufacturing facilities in March. As of today, the FDA is only performing a fraction of
English